Cancer detection using Artificial Intelligence (AI) involves leveraging advanced machine learning algorithms and techniques to identify and diagnose cancer from various medical data sources. The goal is to enhance early detection, improve diagnostic accuracy, and potentially reduce the need for invasive procedures.




Pancreatic cancer is projected to become the second-deadliest malignancy in Western countries by 2030, highlighting the urgent need for better early detection. Intraductal papillary mucinous neoplasms (IPMNs), key precursors to pancreatic cancer, are challenging to assess with current guidelines, often leading to unnecessary surgeries or missed malignancies. We present Cyst-X, an AI framework that predicts IPMN malignancy using multicenter MRI data, leveraging MRI's superior soft tissue contrast over CT. Trained on 723 T1- and 738 T2-weighted scans from 764 patients across seven institutions, our models (AUC=0.82) significantly outperform both Kyoto guidelines (AUC=0.75) and expert radiologists. The AI-derived imaging features align with known clinical markers and offer biologically meaningful insights. We also demonstrate strong performance in a federated learning setting, enabling collaborative training without sharing patient data. To promote privacy-preserving AI development and improve IPMN risk stratification, the Cyst-X dataset is released as the first large-scale, multi-center pancreatic cysts MRI dataset.
Recent discoveries have suggested that the promising avenue of using circulating tumor DNA (ctDNA) levels in blood samples provides reasonable accuracy for cancer monitoring, with extremely low burden on the patient's side. It is known that the presence of ctDNA can result from various mechanisms leading to DNA release from cells, such as apoptosis, necrosis or active secretion. One key idea in recent cancer monitoring studies is that monitoring the dynamics of ctDNA levels might be sufficient for early multi-cancer detection. This interesting idea has been turned into commercial products, e.g. in the company named GRAIL. In the present work, we propose to explore the use of Signature theory for detecting aggressive cancer tumors based on the analysis of blood samples. Our approach combines tools from continuous time Markov modelling for the dynamics of ctDNA levels in the blood, with Signature theory for building efficient testing procedures. Signature theory is a topic of growing interest in the Machine Learning community (see Chevyrev2016 and Fermanian2021), which is now recognised as a powerful feature extraction tool for irregularly sampled signals. The method proposed in the present paper is shown to correctly address the challenging problem of overcoming the inherent data scarsity due to the extremely small number of blood samples per patient. The relevance of our approach is illustrated with extensive numerical experiments that confirm the efficiency of the proposed pipeline.
Spiking Neural Networks (SNNs) event-driven nature enables efficient encoding of spatial and temporal features, making them suitable for dynamic time-dependent data processing. Despite their biological relevance, SNNs have seen limited application in medical image recognition due to difficulties in matching the performance of conventional deep learning models. To address this, we propose a novel breast cancer classification approach that combines SNNs with Lempel-Ziv Complexity (LZC) a computationally efficient measure of sequence complexity. LZC enhances the interpretability and accuracy of spike-based models by capturing structural patterns in neural activity. Our study explores both biophysical Leaky Integrate-and-Fire (LIF) and probabilistic Levy-Baxter (LB) neuron models under supervised, unsupervised, and hybrid learning regimes. Experiments were conducted on the Breast Cancer Wisconsin dataset using numerical features derived from medical imaging. LB-based models consistently exceeded 90.00% accuracy, while LIF-based models reached over 85.00%. The highest accuracy of 98.25% was achieved using an ANN-to-SNN conversion method applied to both neuron models comparable to traditional deep learning with back-propagation, but at up to 100 times lower computational cost. This hybrid approach merges deep learning performance with the efficiency and plausibility of SNNs, yielding top results at lower computational cost. We hypothesize that the synergy between temporal-coding, spike-sparsity, and LZC-driven complexity analysis enables more-efficient feature extraction. Our findings demonstrate that SNNs combined with LZC offer promising, biologically plausible alternative to conventional neural networks in medical diagnostics, particularly for resource-constrained or real-time systems.
Accurate classification of computed tomography (CT) images is essential for diagnosis and treatment planning, but existing methods often struggle with the subtle and spatially diverse nature of pathological features. Current approaches typically process images uniformly, limiting their ability to detect localized abnormalities that require focused analysis. We introduce UGPL, an uncertainty-guided progressive learning framework that performs a global-to-local analysis by first identifying regions of diagnostic ambiguity and then conducting detailed examination of these critical areas. Our approach employs evidential deep learning to quantify predictive uncertainty, guiding the extraction of informative patches through a non-maximum suppression mechanism that maintains spatial diversity. This progressive refinement strategy, combined with an adaptive fusion mechanism, enables UGPL to integrate both contextual information and fine-grained details. Experiments across three CT datasets demonstrate that UGPL consistently outperforms state-of-the-art methods, achieving improvements of 3.29%, 2.46%, and 8.08% in accuracy for kidney abnormality, lung cancer, and COVID-19 detection, respectively. Our analysis shows that the uncertainty-guided component provides substantial benefits, with performance dramatically increasing when the full progressive learning pipeline is implemented. Our code is available at: https://github.com/shravan-18/UGPL
Cell detection, segmentation and classification are essential for analyzing tumor microenvironments (TME) on hematoxylin and eosin (H&E) slides. Existing methods suffer from poor performance on understudied cell types (rare or not present in public datasets) and limited cross-domain generalization. To address these shortcomings, we introduce HistoPLUS, a state-of-the-art model for cell analysis, trained on a novel curated pan-cancer dataset of 108,722 nuclei covering 13 cell types. In external validation across 4 independent cohorts, HistoPLUS outperforms current state-of-the-art models in detection quality by 5.2% and overall F1 classification score by 23.7%, while using 5x fewer parameters. Notably, HistoPLUS unlocks the study of 7 understudied cell types and brings significant improvements on 8 of 13 cell types. Moreover, we show that HistoPLUS robustly transfers to two oncology indications unseen during training. To support broader TME biomarker research, we release the model weights and inference code at https://github.com/owkin/histoplus/.
Colorectal polyp segmentation is critical for early detection of colorectal cancer, yet weak and low contrast boundaries significantly limit automated accuracy. Existing deep models either blur fine edge details or rely on handcrafted filters that perform poorly under variable imaging conditions. We propose MEGANet-W, a Wavelet Driven Edge Guided Attention Network that injects directional, parameter free Haar wavelet edge maps into each decoder stage to recalibrate semantic features. Our two main contributions are: (1) a two-level Haar wavelet head for multi orientation edge extraction; and (2) Wavelet Edge Guided Attention (WEGA) modules that fuse wavelet cues with reverse and input branches. On five public polyp datasets, MEGANetW consistently outperforms existing methods, improving mIoU by up to 2.3% and mDice by 1.2%, while introducing no additional learnable parameters.




Deep learning models have shown promise in lung pathology detection from chest X-rays, but widespread clinical adoption remains limited due to opaque model decision-making. In prior work, we introduced ClinicXAI, a human-centric, expert-guided concept bottleneck model (CBM) designed for interpretable lung cancer diagnosis. We now extend that approach and present XpertXAI, a generalizable expert-driven model that preserves human-interpretable clinical concepts while scaling to detect multiple lung pathologies. Using a high-performing InceptionV3-based classifier and a public dataset of chest X-rays with radiology reports, we compare XpertXAI against leading post-hoc explainability methods and an unsupervised CBM, XCBs. We assess explanations through comparison with expert radiologist annotations and medical ground truth. Although XpertXAI is trained for multiple pathologies, our expert validation focuses on lung cancer. We find that existing techniques frequently fail to produce clinically meaningful explanations, omitting key diagnostic features and disagreeing with radiologist judgments. XpertXAI not only outperforms these baselines in predictive accuracy but also delivers concept-level explanations that better align with expert reasoning. While our focus remains on explainability in lung cancer detection, this work illustrates how human-centric model design can be effectively extended to broader diagnostic contexts - offering a scalable path toward clinically meaningful explainable AI in medical diagnostics.
Colorectal cancer (CRC) remains a leading cause of cancer-related mortality, underscoring the importance of timely polyp detection and diagnosis. While deep learning models have improved optical-assisted diagnostics, they often demand extensive labeled datasets and yield "black-box" outputs with limited interpretability. In this paper, we propose EndoFinder, an online polyp retrieval framework that leverages multi-view scene representations for explainable and scalable CRC diagnosis. First, we develop a Polyp-aware Image Encoder by combining contrastive learning and a reconstruction task, guided by polyp segmentation masks. This self-supervised approach captures robust features without relying on large-scale annotated data. Next, we treat each polyp as a three-dimensional "scene" and introduce a Scene Representation Transformer, which fuses multiple views of the polyp into a single latent representation. By discretizing this representation through a hashing layer, EndoFinder enables real-time retrieval from a compiled database of historical polyp cases, where diagnostic information serves as interpretable references for new queries. We evaluate EndoFinder on both public and newly collected polyp datasets for re-identification and pathology classification. Results show that EndoFinder outperforms existing methods in accuracy while providing transparent, retrieval-based insights for clinical decision-making. By contributing a novel dataset and a scalable, explainable framework, our work addresses key challenges in polyp diagnosis and offers a promising direction for more efficient AI-driven colonoscopy workflows. The source code is available at https://github.com/ku262/EndoFinder-Scene.
Accurate detection of breast cancer from high-resolution mammograms is crucial for early diagnosis and effective treatment planning. Previous studies have shown the potential of using single-view mammograms for breast cancer detection. However, incorporating multi-view data can provide more comprehensive insights. Multi-view classification, especially in medical imaging, presents unique challenges, particularly when dealing with large-scale, high-resolution data. In this work, we propose a novel Multi-view Visual Prompt Tuning Network (MVPT-NET) for analyzing multiple screening mammograms. We first pretrain a robust single-view classification model on high-resolution mammograms and then innovatively adapt multi-view feature learning into a task-specific prompt tuning process. This technique selectively tunes a minimal set of trainable parameters (7\%) while retaining the robustness of the pre-trained single-view model, enabling efficient integration of multi-view data without the need for aggressive downsampling. Our approach offers an efficient alternative to traditional feature fusion methods, providing a more robust, scalable, and efficient solution for high-resolution mammogram analysis. Experimental results on a large multi-institution dataset demonstrate that our method outperforms conventional approaches while maintaining detection efficiency, achieving an AUROC of 0.852 for distinguishing between Benign, DCIS, and Invasive classes. This work highlights the potential of MVPT-NET for medical imaging tasks and provides a scalable solution for integrating multi-view data in breast cancer detection.
Polyp segmentation in colonoscopy images is crucial for early detection and diagnosis of colorectal cancer. However, this task remains a significant challenge due to the substantial variations in polyp shape, size, and color, as well as the high similarity between polyps and surrounding tissues, often compounded by indistinct boundaries. While existing encoder-decoder CNN and transformer-based approaches have shown promising results, they struggle with stable segmentation performance on polyps with weak or blurry boundaries. These methods exhibit limited abilities to distinguish between polyps and non-polyps and capture essential boundary cues. Moreover, their generalizability still falls short of meeting the demands of real-time clinical applications. To address these limitations, we propose SAM-MaGuP, a groundbreaking approach for robust polyp segmentation. By incorporating a boundary distillation module and a 1D-2D Mamba adapter within the Segment Anything Model (SAM), SAM-MaGuP excels at resolving weak boundary challenges and amplifies feature learning through enriched global contextual interactions. Extensive evaluations across five diverse datasets reveal that SAM-MaGuP outperforms state-of-the-art methods, achieving unmatched segmentation accuracy and robustness. Our key innovations, a Mamba-guided boundary prior and a 1D-2D Mamba block, set a new benchmark in the field, pushing the boundaries of polyp segmentation to new heights.